Topics

Aimmune's peanut allergy drug secures FDA panel support, along with criticism

13:15 EDT 13 Sep 2019 | BioPharmaDive

Winning the advisory committee's backing is a major step toward approval, but experts pressed Aimmune with questions on the drug's safety.

Original Article: Aimmune's peanut allergy drug secures FDA panel support, along with criticism

NEXT ARTICLE

More From BioPortfolio on "Aimmune's peanut allergy drug secures FDA panel support, along with criticism"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...